G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells
about
CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1Association between Hsp90 and the ClC-2 chloride channel upregulates channel functionThe role of Cdc25A in the regulation of cell proliferation and apoptosisCombining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment.SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblastsFenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathwayGenome-wide transcriptome profiling of homologous recombination DNA repair.Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693.Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells.p16(INK4a) suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms.Imprinted genes and the environment: links to the toxic metals arsenic, cadmium, lead and mercury.Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.ERK activation is required for CCK-mediated pancreatic adaptive growth in mice.Follistatin could promote the proliferation of duck primary myoblasts by activating PI3K/Akt/mTOR signalling.Synergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells.Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model.LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway.Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications.RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.Mitogenic Signaling by the gep Oncogene Involves the Upregulation of S-Phase Kinase-Associated Protein 2.PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitroRelative Apoptosis-inducing Potential of Homeopa-thic Condurango 6C and 30C in H460 Lung Cancer Cells In vitro: -Apoptosis-induction by homeopathic Condurango in H460 cells.Stratification of clear cell renal cell carcinoma by signaling pathway analysis.Cilium, centrosome and cell cycle regulation in polycystic kidney disease.miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinomaAnti-lung cancer potential of pure esteric-glycoside condurangogenin A against nonsmall-cell lung cancer cells in vitro via p21/p53 mediated cell cycle modulation and DNA damage-induced apoptosis.The different roles of cyclinD1-CDK4 in STP and mGluR-LTD during the postnatal development in mice hippocampus area CA1.Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation.Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drugMorphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients.Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma.PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stabilityβ-hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signalingFrom Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy.Novel treatment strategies for aggressive non-Hodgkin's lymphoma.Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
P2860
Q24310613-49CE2D95-CD09-48F2-944F-FAAC3C22E05AQ28263936-F86DAFD3-A10F-4394-A4A4-28B9E37F98FDQ28611420-93CB7037-D1F2-4E18-970F-5D8345CAD155Q31120012-ADBCF490-654A-45CD-B2D7-827A18D72C93Q33322514-6476D495-E714-48BB-8AC2-D6F9C1D8C361Q33589182-7EAD3162-AA37-4EA9-ABAA-8A8FDD4C9D41Q33598112-CA437275-90B5-4F6E-8933-84B0812AC80FQ33626022-8C5F51CF-8AA7-420C-B5DB-540A9DF9449BQ33699826-C434AAB3-6090-424B-A2CB-B6717D3360E3Q33717075-9EE1EF3A-D436-4AF7-9AE8-A2D34BF558D1Q33812880-5CB661D1-1ED6-42B5-B428-1985A25F0372Q33842306-972C2776-E9AB-4BE7-9437-0EE114B46157Q33891724-E8FBFDF1-9092-4A04-B247-9934385D0E33Q33959320-498A1F56-D2F5-4B45-AF29-E9D587D49218Q34295427-7CF1F8A9-1FB7-4497-89ED-088BC0F0C82FQ34360495-31FB099C-E44A-41C0-9228-663E60FF1209Q34377965-6F44E22B-2879-4340-BE4C-301CDC19A6B8Q34405324-9B051638-039A-429A-B6B5-14940649DE80Q34487171-EA34DDD2-42A2-4980-BA9D-D161837C3430Q34566745-48D1752B-C915-4057-A385-D32576D92F17Q34576512-A02DB8D9-F634-4309-97B5-B71A7A8E16A4Q34866982-5EF90BCE-7D49-4F90-99A2-D6AD30261476Q35089274-9FC79447-2D32-49EB-A87A-7EA929A44588Q35093649-9D567CAB-5761-4328-A59C-BDE2A5602292Q35103884-57D009B2-255C-4A50-82C1-AA98B155BB1AQ35112926-C237AE50-3337-48BD-85FC-4105DB2ADF0EQ35177212-87E0AAB2-566B-4A07-9A85-A6245567F6BCQ35691439-096744C1-FC61-4084-B764-5C29FA782718Q35709966-76AC97C6-F5F2-4E1A-BA6D-B1428D03D21DQ35840229-1C808E5F-4E22-40DB-9A08-219CD464EA20Q35875613-D20C5DA8-62B1-4C92-AE3E-0AE8127F447AQ36071788-AE32E6CB-6962-41C8-9BF2-E12FC29CD666Q36184798-ACBD7207-CC15-4011-894E-7544C580857CQ36224947-D1B178DB-C2CB-4B90-A28E-A4E01E0C7EE8Q36299687-56494138-353C-4087-8C84-753CE14F3AC8Q36334776-96C0B476-6591-492C-B7C4-DE50BBFF1B4BQ36352100-150AFDB8-AC95-4CA0-A45F-4AA9D0CFA04DQ36429727-15B8C06D-7C4F-42C7-B483-D96E305A3D8AQ36705677-B6A91737-097E-4665-855C-4544B47C6633Q36782423-96EEF726-EAB0-4408-8512-7E9486EBB6B0
P2860
G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
G1 cell cycle progression and ...... in human ovarian cancer cells
@ast
G1 cell cycle progression and ...... in human ovarian cancer cells
@en
G1 cell cycle progression and ...... in human ovarian cancer cells
@en-gb
G1 cell cycle progression and ...... in human ovarian cancer cells
@nl
type
label
G1 cell cycle progression and ...... in human ovarian cancer cells
@ast
G1 cell cycle progression and ...... in human ovarian cancer cells
@en
G1 cell cycle progression and ...... in human ovarian cancer cells
@en-gb
G1 cell cycle progression and ...... in human ovarian cancer cells
@nl
prefLabel
G1 cell cycle progression and ...... in human ovarian cancer cells
@ast
G1 cell cycle progression and ...... in human ovarian cancer cells
@en
G1 cell cycle progression and ...... in human ovarian cancer cells
@en-gb
G1 cell cycle progression and ...... in human ovarian cancer cells
@nl
P921
P1476
G1 cell cycle progression and ...... in human ovarian cancer cells
@en
P2093
P2880
P304
P356
10.1152/AJPCELL.00422.2003
P407
P577
2004-03-24T00:00:00Z